The Dubai International Pharmaceutical & Technology Exhibition

The Dubai International Pharmaceutical & Technology Exhibition (DUPHAT) was first held in 1995 and has been held for 30 consecutive years (the 30th edition will be in 2025). It is the oldest and largest professional pharmaceutical exhibition in the Middle East and North Africa.

I. Core Achievements and Influence of the Exhibition

1. Industry Status: The No.1 Pharmaceutical Exhibition in the Middle East and Africa

Longest History: Founded in 1995, it is the first professional pharmaceutical exhibition in the Middle East, witnessing and promoting the transformation of the regional pharmaceutical industry from import dependence to self-sufficiency in production.

Largest Scale: Maintaining the number one position in the Middle East and Africa for many consecutive years in terms of exhibitors, visitors, and exhibition area. The 2025 edition will feature exhibitors from 101 countries and visitors from over 60 countries/regions.

Authoritative Recognition: Endorsed by the Dubai Health Authority, the GCC Pharmaceutical Committee, and the WHO, it serves as a bellwether for pharmaceutical compliance and market access in the Middle East.

2. Trade Achievements: A Global Pharmaceutical Trade Hub

Core of Re-export Trade: Leveraging the advantages of the Dubai Free Trade Port, it has become a re-export center for global pharmaceutical products entering the Middle East, Africa, and South Asia. The re-export tax rate is only 1%, significantly reducing trade costs.

Highly Efficient Order Conversion: The 2025 edition facilitated over 200... The cooperation intentions cover R&D, technology transfer, supply chain, and distribution;

Key to Channel Building: Helping global companies quickly connect with first-tier distributors in the Middle East, local pharmaceutical manufacturers, and government procurement agencies, shortening the market entry cycle by 6-12 months.

3. Technological and Innovative Achievements

Cutting-Edge Technology Launch Platform: Global pharmaceutical companies showcase technologies such as intelligent pharmaceutical manufacturing, nano-formulations, green synthesis, and AI quality inspection, such as new green synthesis processes reducing costs by 30% and AI quality inspection error rates controlled at 0.01%.

Industry Collaboration Promoter: Connecting the entire chain of APIs, intermediates, formulations, equipment, packaging, and CDMO, promoting the clustering and localization of the Middle Eastern pharmaceutical industry (the UAE and Saudi Arabia are accelerating the promotion of medical self-sufficiency).

Academic and Compliance Hub: Inviting over 1500 global experts to speak, releasing Middle Eastern pharmaceutical policies, registration standards, and GMP requirements, serving as a core channel for companies to obtain GCC registration, WHO-PQ, and local compliance information.

4. Unique Value for Chinese Companies

Middle East and African Market Springboard: China API, plant extract, generic drug, and pharmaceutical equipment companies can directly connect with regional buyers at the exhibition, bypassing multi-level distribution and increasing profit margins.

Compliance Access Shortcut: Directly engage with Middle Eastern regulatory and certification bodies on-site to quickly resolve access challenges such as GMP, Certificate of Free Sale, Certificate of Authorization (COA), and labeling compliance.

5. Global Influence

Regional Reach: Centered in Dubai, covering Saudi Arabia, Egypt, Kuwait, Iran, Turkey, Pakistan, and 54 African countries, it is the only global pharmaceutical exhibition simultaneously reaching the Middle East, Africa, and South Asia.

Industry Benchmark Effect: Becoming a Middle Eastern and African model for global pharmaceutical exhibitions, promoting the standardization and internationalization of the regional pharmaceutical market, and helping the Middle East become a new growth pole for the global pharmaceutical industry.